Perspective Therapeutics (CATX) Capital Expenditures (2010 - 2026)
Perspective Therapeutics (CATX) reported Capital Expenditures of $14.2 million for Q2 2026, compared with $1.03 million a year earlier and up 107.0% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Perspective Therapeutics' Capital Expenditures came in at $28.12 million, down 43.8% year-over-year; for FY2025, it was $12.75 million, down 76.6% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 115.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $54.41 million in FY2024, $1.07 million in FY2023 (+280.1%), $282,000 in FY2022 and $381,000 in FY2021 (+39.6%).
- The Q2 2026 figure ranks as the highest quarterly Capital Expenditures since Q4 2024.
- Year over year, Capital Expenditures gained in two of the last five quarters, with an average decline of 31.8%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.86 million (Q1 2026), $5.08 million (Q4 2025) and $1.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Perspective Therapeutics | 285.22 Mn | 285.22 Mn | - | 14.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.20 Mn |
| Mar 31, 2026 | 6.86 Mn |
| Dec 31, 2025 | 5.08 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 14.61 Mn |
| Sep 30, 2024 | 29.71 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 9.07 Mn |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | 227,000.00 |
| Jun 30, 2023 | 555,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | 90,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 81,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Jun 30, 2021 | 115,000.00 |
API Access
Perspective Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();